Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, August 20, 2014
 
Register | Sign in
Home Page>Products
  Product News
Siemens Showcases New Workflow, Testing and Training Solutions
Thursday, July 31, 2014
Company unveils its in vitro diagnostics innovations at the 2014 AACC.

Siemens Unveils New Chemistry and Immunoassay Systems
Thursday, July 31, 2014
Company introduces the ADVIA Chemistry XPT and ADVIA Centaur XPT Immunoassay System at AACC 2014.

AB SCIEX Announces the 4500MD Series* for In Vitro Diagnostic Use
Tuesday, July 29, 2014
Industry leader increases mass spectrometry portfolio for clinical testing laboratories.

Core Informatics Releases Core ELN Chemistry Application on Platform for Science
Monday, July 28, 2014
Newly developed application is designed to help chemists document research activities and compound registration in the cloud.

IBM introduces Storage as a Service on SoftLayer for High Performance Data Management in Cloud
Monday, July 28, 2014
IBM introduces Storage as a Service on SoftLayer for High Performance Data Management in Cloud

New Phenomenex GC Column Set for Chlorinated Pesticides
Friday, July 25, 2014
The Zebron ZB-CLPesticides GC column runs seven EPA methods.

MDxI Launches LabFile Data Resource
Friday, July 25, 2014
New standard for defining and targeting US clinical laboratory universe.

Cancer Conference Poster Prize Winner
Friday, July 25, 2014
Katarzyna Grzes announced as the winner of the AMSBIO-Trevigen prize for the best poster.

Reliable Assays for Sugars in Acid-Hydrolyzed Wood
Friday, July 25, 2014
Determination of common sugars by high-performance anion-exchange chromatography with pulsed amperometric detection methods.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 10413
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv